Armata CFO Steve Martin to retire June 30; Erin Butler named successor as CFO & VP Finance

Armata Pharmaceuticals, Inc.

CFO Steve R. Martin to retire effective June 30, 2022; will serve as advisor through Dec 31, 2022.
Martin to receive continued base salary ($389,340/yr) during transition; half of unvested options to vest at end.
Erin Butler appointed VP Finance & Admin (April 1) and Principal Financial & Accounting Officer (July 1).
Butler's compensation: $290K base salary, 30% target bonus, option for 50,000 shares vesting over 4 years.
Butler to get 6 months severance on involuntary termination; full equity acceleration on change in control.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Steve R. Martin

Chief Financial Officer and Senior Vice President

ARMP · Armata Pharmaceuticals, Inc.

Effective: 2022-06-30
Successor: Erin Butler
Filed: March 28, 2022, 7:59 PM ET

On March 25, 2022, Steve R. Martin notified Armata Pharmaceuticals, Inc. (the “Company”) that he intends to retire as Chief Financial Officer and Senior Vice President (and Principal Financial and Accounting Officer) of the Company effective as of June 30, 2022 (the “Transition Date”).

Appointed

Erin Butler

Vice President of Finance and Administration and Principal Financial and Accounting Officer

ARMP · Armata Pharmaceuticals, Inc.

Effective: 2022-07-01
Filed: March 28, 2022, 7:59 PM ET

On March 25, 2022, the Board appointed Erin Butler to serve as (i) Vice President of Finance and Administration of the Company, effective April 1, 2022, and (ii) Principal Financial and Accounting Officer of the Company, effective July 1, 2022.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Steve R. Martin departed as Chief Financial Officer and Senior Vice President at Armata Pharmaceuticals, Inc..

Action: retire
Role: Chief Financial Officer and Senior Vice President

Exact text from the filing

On March 25, 2022, Steve R. Martin notified Armata Pharmaceuticals, Inc. (the “Company”) that he intends to retire as Chief Financial Officer and Senior Vice President (and Principal Financial and Accounting Officer) of the Company effective as of June 30, 2022 (the “Transition Date”).

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Erin Butler was appointed as Vice President of Finance and Administration and Principal Financial and Accounting Officer at Armata Pharmaceuticals, Inc..

Action: appointed
Role: Vice President of Finance and Administration and Principal Financial and Accounting Officer

Exact text from the filing

On March 25, 2022, the Board appointed Erin Butler to serve as (i) Vice President of Finance and Administration of the Company, effective April 1, 2022, and (ii) Principal Financial and Accounting Officer of the Company, effective July 1, 2022.

View on SEC.gov

Armata Pharmaceuticals, Inc. filing history →

Source: SEC EDGAR

accession 0001104659-22-038851

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.